| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrine Care |
Department of Community Health (A.V.), Brown Medical School, Providence, Rhode Island 02912; Department of Pediatrics (C.M.B.), Division of Endocrinology and Metabolism, Rhode Island Hospital, Brown Medical School, Providence, Rhode Island 02903; and Department of Pediatrics (R.T., B.R.V.), Women and Infants Hospital, Brown Medical School, Providence, Rhode Island 02905
Address all correspondence and requests for reprints to: Betty R. Vohr, M.D., Women and Infants Hospital, 101 Dudley Street, Providence, Rhode Island 02905. E-mail: . bvohr{at}wihri.org
Abstract
The purpose of this study was to determine the prevalence of insulin resistance syndrome (IRS) and the risk factors for developing IRS among women with a history of gestational diabetes mellitus (GDM), compared with controls over 11 postdelivery years. Assessments of 106 women with a prior history of GDM and 101 controls were done on six occasions from 411 yr after delivery. Tests included glucose, insulin, lipids, blood pressure, and body measurements. The risk of IRS was analyzed by Cox regression. The results were that 27.2% of GDM and 8.2% of controls developed IRS by 11 yr after delivery. The hazard of developing IRS was 5.6 times (95% confidence interval = 2.612.3) among women with prepregnant obesity (body mass index >27.3 kg/m2), compared with women without prepregnant obesity and 4.4 times (95% confidence interval = 1.711.1) in women with a history of GDM, compared with controls. At 11 yr after delivery, the cumulative hazard for developing IRS in the next 2 yr was 26 times higher among GDM with prepregnant obesity, compared with controls without prepregnant obesity. We concluded that obesity and GDM in a prior pregnancy are significant risk factors for developing IRS over time. Early detection of markers of IRS is vital for possible prevention of type 2 diabetes and cardiovascular adverse events in women.
This article has been cited by other articles:
![]() |
C. Kim, Y. J. Cheng, and G. L. Beckles Cardiovascular Disease Risk Profiles in Women With Histories of Gestational Diabetes but Without Current Diabetes Obstet. Gynecol., October 1, 2008; 112(4): 875 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Shah, R. Retnakaran, and G. L. Booth Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus Diabetes Care, August 1, 2008; 31(8): 1668 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Kitzmiller, L. Dang-Kilduff, and M. M. Taslimi Gestational Diabetes After Delivery: Short-term management and long-term risks Diabetes Care, July 1, 2007; 30(Supplement_2): S225 - S235. [Full Text] [PDF] |
||||
![]() |
P. Damm, E. R. Mathiesen, K. R. Petersen, and S. Kjos Contraception After Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S236 - S241. [Full Text] [PDF] |
||||
![]() |
D. B. Carr, K. M. Utzschneider, R. L. Hull, J. Tong, T. M. Wallace, K. Kodama, J. B. Shofer, S. R. Heckbert, E. J. Boyko, W. Y. Fujimoto, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care, September 1, 2006; 29(9): 2078 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Heitritter, C. G. Solomon, G. F. Mitchell, N. Skali-Ounis, and E. W. Seely Subclinical Inflammation and Vascular Dysfunction in Women with Previous Gestational Diabetes Mellitus J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3983 - 3988. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lauenborg, E. Mathiesen, T. Hansen, C. Glumer, T. Jorgensen, K. Borch-Johnsen, P. Hornnes, O. Pedersen, and P. Damm The Prevalence of the Metabolic Syndrome in a Danish Population of Women with Previous Gestational Diabetes Mellitus Is Three-Fold Higher than in the General Population J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4004 - 4010. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Boney, A. Verma, R. Tucker, and B. R. Vohr Metabolic Syndrome in Childhood: Association With Birth Weight, Maternal Obesity, and Gestational Diabetes Mellitus Pediatrics, March 1, 2005; 115(3): e290 - e296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wolf, J. Sauk, A. Shah, K. Vossen Smirnakis, R. Jimenez-Kimble, J. L. Ecker, and R. Thadhani Inflammation and Glucose Intolerance: A prospective study of gestational diabetes mellitus Diabetes Care, January 1, 2004; 27(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |